Moderate-to-Severe Acne Treatment Market

Global Moderate-to-Severe Acne Treatment Market Snapshot (2023 to 2033)

The global moderate-to-severe acne treatment market was valued at USD 1.2 Billion in 2022 and is expected to reach USD 2.4 Billion by 2033. The retinoid therapy with around 25.6% value share, has topped the global market within the treatment category in 2022 and is expected to grow at a CAGR of close to 6.5% over the forecast period (2023 to 2033).

Market Outlook:

Data Points	Market Insights
Market Value 2022	USD 1.2 Billion
Market Value 2023	USD 1.3 Billion
Market Value 2033	USD 2.4 Billion
CAGR 2023 to 2033	6.5%
Market Share of Top 5 Countries	57.4%
Key Market Players	Johnson & Johnson; Bayer AG; Galderma; Allergan; Roche; ;Valeant Pharmaceuticals; Stiefel Laboratories; Pfizer; Foamix Pharmaceuticals; La Roche-Posay; Proactiv; Cipla Limited; GlaxoSmithKline; Janssen Pharmaceuticals Inc. & Sanofi.

Acne is a prevalent skin condition, affecting millions of people worldwide. The incidence of moderate-to-severe acne has been increasing, driven by factors such as hormonal changes, lifestyle habits, and genetic predisposition. This growing prevalence fuels the demand for effective treatments.

There is a growing awareness among individuals about the impact of acne on their appearance and quality of life. More people with moderate-to-severe acne are seeking professional treatment and are willing to invest in products and therapies to address their condition, driving market growth.

Economic growth and rising disposable incomes in many regions have led to increased healthcare spending. Individuals are willing to invest in premium skincare products, dermatology consultations, and advanced acne treatments. This trend boosts the demand for moderate-to-severe acne treatment products and therapies.

Sales Analysis of Moderate-to-Severe Acne Treatment Market from 2017 to 2022 Vs Market Outlook for 2023 to 2033

The global market for moderate-to-severe acne treatment was around 12.5% of the overall USD 9.6 Billion of the global acne treatment market in 2022.

There is a growing demand for effective treatments for moderate-to-severe acne. Individuals with more severe forms of acne often seek professional help and are willing to invest in products and therapies that can provide significant improvement. The increasing awareness and social impact of acne drive the demand for treatments, contributing to sales growth.

Advancements in acne treatment have led to more effective therapies for moderate-to-severe acne. New ingredients, formulations, and delivery systems enhance treatment outcomes and reduce the severity and duration of acne lesions. The improved efficacy of treatments increases patient satisfaction and contributes to sales growth.

Increased awareness about the impact of acne on physical appearance and quality of life has led individuals to seek professional treatment. Educational campaigns and information dissemination through various media platforms have improved awareness about the availability of effective treatments for moderate-to-severe acne. This increased awareness has driven sales growth in the market.

Owed to the above factors, the global market is projected to grow at CAGR of 6.5% in forecasted period.

What are the Key Opportunities for the Manufacturers?

There is huge opportunity for market players to develop and introduce advanced treatment modalities for moderate-to-severe acne. This includes exploring innovative technologies such as laser therapies, light-based treatments, chemical peels, and photodynamic therapy. Advancements in these modalities provide more effective and efficient acne treatment options, attracting both patients and healthcare professionals.

Combination therapies involving the use of multiple treatment modalities or a combination of medications offer an opportunity for improved outcomes in moderate-to-severe acne treatment. By combining different therapeutic approaches, such as topical medications, oral medications, and physical treatments, synergistic effects can be achieved, leading to better efficacy and patient satisfaction.

The demand for skincare products specifically formulated for moderate-to-severe acne presents an opportunity for new product development. This includes the development of non-comedogenic, oil-free, and acne-fighting skincare products that address the unique needs of individuals with moderate-to-severe acne. Targeted skincare products can complement medical treatments and improve overall outcomes.

The integration of telemedicine and digital health solutions in acne treatment offers opportunities for remote consultations, follow-up care, and patient monitoring. Telemedicine platforms can enable access to specialized dermatological care, particularly in underserved areas. Digital health tools, such as mobile applications for acne tracking and management, can enhance patient engagement and treatment adherence.

What are the Factors Restraining the Demand for Moderate-to-Severe Acne Treatment?

The cost of moderate-to-severe acne treatments, including prescription medications and procedures, can be a significant barrier for some individuals. Expensive treatments may not be accessible or affordable for all patients, limiting their options for effective acne management. The cost-effectiveness of treatments and insurance coverage play crucial roles in addressing this restraint.

Access to specialized dermatological care can be limited in some regions or underserved areas. The availability of dermatologists and specialized clinics may be scarce, making it challenging for individuals with moderate-to-severe acne to receive timely and appropriate treatment. Improving access to dermatological care is essential to address this restraint.

Antibiotics are commonly used in the treatment of moderate-to-severe acne, but antibiotic resistance is a growing concern. Prolonged or inappropriate use of antibiotics can contribute to the development of resistant bacteria, reducing treatment efficacy and limiting future treatment options. Finding alternative approaches to acne treatment and reducing reliance on antibiotics are important considerations.

Country-wise Insights

Why is USA a Prominent Market for Moderate-to-Severe Acne Treatment in North America Region?

The USA occupies 37.4% of market share in 2022 globally. The pharmaceutical industry plays a crucial role in the moderate-to-severe acne treatment market in the United States. Several companies develop and market prescription medications specifically indicated for moderate-to-severe acne. These medications include topical formulations, oral medications, and combination therapies. The pharmaceutical market's dynamics, including competition and pricing, influence the availability and accessibility of acne treatments. This makes USA prominent market for moderate-to-severe acne treatment in North America.

What Makes Japan a Highly Lucrative Market for Moderate-to-Severe Acne Treatment?

Japan expenditure on moderate-to-severe acne treatment in 2022 was USD 61.9 Million. Japan is at the forefront of technological advancements in the healthcare industry. Japan is known for its advancements in skincare technology and product development. The market offers a wide range of innovative acne treatment products, including topical formulations, skincare devices, and specialized cosmetics. Advanced technology and unique formulations contribute to the growth and competitiveness of the market.

Traditional and natural skincare approaches have a significant presence in the Japanese market. Some individuals with moderate-to-severe acne may seek alternative treatments, including herbal remedies, traditional medicine, and natural skincare products.

What Makes the China a Large Market for Moderate-to-Severe Acne Treatment?

In 2022, the China held a significant share in the East Asia market and is expected to present lucrative growth of 6.1% CAGR over the forecast period. China has a thriving e-commerce market, and online platforms play a significant role in the distribution and sales of skincare products, including acne treatments. Online shopping platforms provide convenience and accessibility, allowing individuals to access a wide range of products for moderate-to-severe acne treatment.

Chinese consumers are becoming more educated about skincare and are increasingly focused on maintaining healthy and clear skin. They are receptive to innovative skincare products and treatment options, including those targeted at moderate-to-severe acne.

Category-wise Insights

Which Treatment is Predicted to Expand Rapidly Between 2023 and 2033?

By treatment, retinoid therapy held 25.6% market share in world in 2022.

The moderate-to-severe acne treatment market, specifically focusing on retinoid therapy, is a significant segment within the dermatology market. Retinoids are a class of medications derived from vitamin A that are commonly used in the treatment of acne. They work by reducing inflammation, promoting skin cell turnover, and preventing the formation of comedones.

Retinoids, including topical retinoids like tretinoin, adapalene, and tazarotene, have been proven to be highly effective in treating moderate-to-severe acne. Their ability to target multiple aspects of acne pathogenesis contributes to their popularity and market demand.

Which Route of Administration is Preferred Prominently in Moderate-to-Severe Acne Treatment?

The market value of topical mode is USD 574.3 Million, representing a sizable 46.1% market share in 2022. The moderate-to-severe acne treatment market, with a focus on topical treatments, plays a crucial role in addressing the needs of individuals with more severe forms of acne. Topical treatments are applied directly to the skin and can include various formulations and active ingredients targeting acne symptoms and underlying causes.

Combination topical therapies are commonly prescribed for moderate-to-severe acne. These combinations may include a combination of active ingredients such as retinoids, benzoyl peroxide, antibiotics, or azelaic acid. Combining different agents with complementary mechanisms of action can provide enhanced efficacy in managing acne symptoms.

Which Distribution Channel is Benefiting the Global Market?

The hospitals have a considerable presence in the moderate-to-severe acne treatment market, accounting for 34.9% value share in 2022, and exhibiting a high CAGR of 5.2% over the forecast period. In some cases, individuals with severe acne may require hospitalization for intensive treatment. This is typically reserved for cases where acne is causing significant physical or psychological distress and requires specialized care. Inpatient dermatology services in hospitals can provide a multidisciplinary approach to managing severe acne.

Some hospitals have specialized dermatology departments equipped with phototherapy units and laser devices. These treatments can be used in the management of moderate-to-severe acne, particularly for patients who have not responded well to conventional therapies.

Competitive Landscape

Various firms active within the acne treatment industry are actively seeking collaborations with healthcare providers, and research institutions to can encourage innovation. Introduction of new and effective treatment modalities has been emphasized a lot.

• In June 2022, Cipla Limited confirmed that it had agreed to pay INR 25.90 crore for an additional share in GoApptiv Private Limited. After the transaction is completed, Cipla's overall ownership in GoApptiv will rise to 22.02% on a fully diluted basis.
• In March 2023, Galderma recently unveiled FACE, a modern aesthetic visualisation tool driven with augmented reality (AR) which allows dermatologists and patients to preview injectable therapy outcomes prior to starting a procedure.

Similarly, recent developments related to the companies active within the moderate-to-severe acne treatment have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as Per Moderate-to-Severe Acne Treatment Industry Analysis

Attribute	Details
Forecast Period	2023 to 2033
Historical Data Available for	2017 to 2022
Market Analysis	USD Million for Value
Key Regions Covered	North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East and Africa (MEA)
Key Countries Covered	USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Spain, BENELUX, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC countries, Türkiye, Northern Africa and South Africa.
Key Market Segments Covered	Treatment, Route of Administration, Distribution Channel and Region
Key Companies Profiled	Johnson & Johnson; Bayer AG; Galderma; Allergan; Roche; Valeant Pharmaceuticals; Stiefel Laboratories; Pfizer; Foamix Pharmaceuticals; La Roche-Posay; Proactiv; Cipla Limited; GlaxoSmithKline Inc.; Janssen Pharmaceuticals Inc.; Sanofi
Report Coverage	Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Pricing	Available upon Request

Key Market Segments Covered in the Moderate-to-Severe Acne Treatment Industry Research

By Treatment:

• Antibiotics
• Retinoid Therapy
• Hormonal Drugs
• Anti-Inflammatory Drugs
• Chemical Peels
• Laser Devices
• Radiofrequency devices

By Route of Administration:

• Oral
• Topical
• Injectables

By Distribution Channel:

• Hospitals
• Clinics
• Pharmacies & Drug Stores
• e-Commerce
• Others

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

Frequently Asked Questions

What is the Market Size of Moderate-to-Severe Acne Treatment?

The market size of moderate-to-severe acne treatment is USD 1.3 billion in 2023.

How are the Growth Scope of the Market?

The market is expected to expand at a CAGR of 6.2%.

Which Factors are Invigorating the Market Growth?

Increasing investment in therapies and products and social impact of acne.

Which is the Most Effective Acne Treatment?

The most effective acne treatment is retinoid therapy.

Which Country Holds Massive Market Portion?

The United States holds massive portion of the market.